4-Amino-6-methoxypyrimidine | CAS:696-45-7

We serve 4-Amino-6-methoxypyrimidine CAS:696-45-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-Amino-6-methoxypyrimidine

Chemical Name:4-Amino-6-methoxypyrimidine
CAS.NO:696-45-7
Synonyms:4-Amino-6-methoxypyrimidine
6-methoxypyrimidin-4-amine
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 290.8±20.0 °C at 760 mmHg
Melting Point 157-160 °C(lit.)
Molecular Formula C5H7N3O
Molecular Weight 125.129
Flash Point 129.7±21.8 °C
Vapour Pressure 0.0±0.6 mmHg at 25°C
Index of Refraction 1.567
 
Specification:
Appearance:White to yellow to orange powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Sulfamethazine(CAS:57-68-1).



Contact us for information like 4-Amino-6-methoxypyrimidine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-methoxypyrimidin-4-amine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Amino-6-methoxypyrimidine Use and application,4-Amino-6-methoxypyrimidine technical grade,usp/ep/jp grade.


Related News: There’s still a lot we don’t know about the coronavirus, and scientists internationally are racing to gather data and develop a treatment.7-chloroheptan-1-ol manufacturer In addition, with the increase of environmental protection pressure, nearly one hundred Beijing pharmaceutical companies have gathered in the Bohai Bay, and the raw material drug base in northern China has taken shape.acetohydrazide supplier In addition, with the increase of environmental protection pressure, nearly one hundred Beijing pharmaceutical companies have gathered in the Bohai Bay, and the raw material drug base in northern China has taken shape.[(2S,3R,5R)-5-chloro-3-(4-chlorobenzoyl)oxyoxolan-2-yl]methyl 4-chlorobenzoate vendor Because API companies usually adopt a different synthetic route from the original research company, compared with the drug itself, the impurities contained in the generic drug API have not been verified by the original drug for many years of use and require more careful testing and control.ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment’s chemistry, manufacturing and controls process, but not its safety.